McKesson is planning to sell Canadian drugstore chain Rexall Pharmacy Group seven years after the US drug distributor bought the business for about C$3bn ($2.2bn).
Read the full article on the Reuters website
McKesson is planning to sell Canadian drugstore chain Rexall Pharmacy Group seven years after the US drug distributor bought the business for about C$3bn ($2.2bn).
Read the full article on the Reuters website
